Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by VLACHOYIANNOPOULOS, P. G.
Right arrow Articles by MOUTSOPOULOS, H. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by VLACHOYIANNOPOULOS, P. G.
Right arrow Articles by MOUTSOPOULOS, H. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1996 British Society for Rheumatology

other

PREDOMINANCE OF IgM ANTI-U1RNP ANTIBODIES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

P. G. VLACHOYIANNOPOULOS, A. GUIALIS*, A. G. TZIOUFAS and H. M. MOUTSOPOULOS

*Institute of Biological Research and Biotechnology, The National Hellenic Research Foundation Vassileos Constantinou Avenue, Athens 116 35, Greece
Department of Pathophysiology, University of Athens, Medical School 75 Mikras Asias Street, Athens 115 27

Correspondence to: Correspondence to: H. M. Moutsopoulos, Department of Pathophysiology, University of Athens Medical School, 75 Mikras Asias Street, Athena 115 27, Greece.

Anti-UIRNP antibodies occur in patients with mixed connective tissue disease (MCTD), systemic sclerosis (SSc), systemic lupus erythematosus (SLE) and other ill-defined connective tissue diseases. To associate the isotypes of anti-UlRNP antibodies with the diagnosis of the disease, namely SLE or MCTD, sequential sera of patients positive for anti-UlRNP antibodies by counterimmunoelectrophorcsis (CIE) (32 with SLE, 35 with MCTD) were tested for IgG and IgM anti-UlRNP antibodies by enzyme-linked immunosorbent assay (ELISA) using affinity-purified UlsnRNP complexes. Results from ELISA were confirmed by RNA precipitation. IgG RNA precipitation of HeLa cellular extracts was performed using the bulk of the IgG fraction removed from each serum after binding to protein A-Sepharose beads. IgM RNA precipitation was carried out on the IgM fraction of the serum bound to protein A-Scpharose-rabbit anti-human IgM immune complexes. RNAs were electrophoresed in 10.5% acrylamide-7 m urea gels and detected with the silver stain. ELISA showed that all sera were positive to IgG anti-UlRNP, while 12 of the 35 MCTD and 21 of the 32 SLE patients possessed IgM anti-UlRNP (P<0.025). IgM anti-UlRNP reactivity was found during the follow-up in 20% of 44 sera from 17 MCTD patients and 68% of 112 sera from 23 SLE patients (P<0.0001). IgG from all the sera precipitated UlRNPs. Eight of the MCTD sera also precipitated U2RNPs and 14 of the SLE sera U2 and/or U4/U6, U5 RNPs. IgM from MCTD sera did not precipitate URNPs, while IgM from SLE sera precipitated predominantly UlRNPs. These data suggest that IgM anti-UlRNP antibodies occur predominantly in patients with SLE. The occurrence of IgG anti-UlRNP without IgM is more frequent in MCTD.

KEY WORDS: Anti-UIRNP, Anti-Sm, Autoanubodies, Isotypes, SLE, MCTD


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Clin. Pathol.Home page
W. Egner
The use of laboratory tests in the diagnosis of SLE
J. Clin. Pathol., June 1, 2000; 53(6): 424 - 432.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.